Position in NTRA
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$27,795,937
+$9,170,469 QoQ
Shares Held
102,398
+9.9% QoQ
Ownership
0.071%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#128
of 846 holders
Holding Since
Mar 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NTRA Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Gotham Asset Management, LLC holds $550,105,949 across 22 Diagnostics & Research names. NTRA ranks #7 (5.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CRL |
Charles River Laboratories International, Inc.
|
433,146 | $98,233,181 | |
| 2 | TMO |
Thermo Fisher Scientific Inc.
|
139,499 | $69,939,218 | |
| 3 | ILMN |
Illumina, Inc.
|
356,183 | $62,627,656 | |
| 4 | DHR |
Danaher Corp /De/
|
235,913 | $44,936,708 | |
| 5 | SHC |
Sotera Health Co
|
2,206,457 | $39,164,611 | |
| 6 | A |
Agilent Technologies, Inc.
|
256,435 | $34,062,261 | |
| 7 | NTRA |
Natera, Inc.
This page
|
102,398 | $27,795,937 | |
| 8 | IQV |
Iqvia Holdings Inc.
|
140,692 | $27,184,508 |
All Filings in NTRA
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $27,795,937 | 102,398 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $18,625,468 | 93,132 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $18,617,227 | 81,266 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $11,529,637 | 71,626 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $17,166,162 | 101,611 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $16,206,010 | 114,603 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $17,334,483 | 109,504 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $12,645,362 | 99,609 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $9,358,096 | 86,417 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $5,640,429 | 61,671 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $3,268,805 | 52,184 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $1,682,075 | 38,013 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $2,139,288 | 43,964 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $2,951,831 | 53,167 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $1,300,865 | 32,384 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $2,235,433 | 51,014 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $1,390,913 | 39,247 | Shares | Sole | 2022-08-15 | |
| 2021-09-30 | $251,965 | 2,261 | Shares | Sole | 2021-11-15 | |
| 2021-03-31 | $947,165 | 9,328 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $4,293,690 | 43,144 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $3,221,976 | 44,601 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $5,508,632 | 110,482 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $745,096 | 24,953 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||